Drug Profile
Octreotide - Pharm-Sintez
Alternative Names: Octreotide-depo; Oktreotid-depoLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Pharm-Sintez
- Class Antidiarrhoeals; Antineoplastics; Antisecretories; Cyclic peptides; Eye disorder therapies; Indoles; Somatostatins
- Mechanism of Action Growth hormone-releasing hormone inhibitors; Somatostatin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Acromegaly; Gastrointestinal cancer; Haemorrhage; Pancreatic cancer; Pancreatitis; Prostate cancer